Literature DB >> 149758

Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell line.

J J Lightbody, W D Peterson, M D Poulik.   

Abstract

The DAUDI lymphoblast cell line derived from a patient with Burkitt lymphoma was obtained from two different sources. One of these (DAUDI-I) produced a factor that inhibited lymphocyte proliferation in both human and mouse regardless of the stimulator, i.e. allogeneic lymphocytes or mitogens. Glutaraldehyde treatment eliminated production of the factor and demonstrated that DAUDI-I was capable of stimulating normal lymphocytes in MLR. A second DAUDI cell line (DAUDI-S) did not produce the inhibitory factor and was capable of MLR stimulation.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 149758     DOI： 10.1007/bf02616109

Source DB:  PubMed          Journal:  In Vitro        ISSN： 0073-5655


  20 in total

1.  Lymphocyte stimulation in vitro: generation of cytotoxic effector lymphocytes using subcellular fractions of a lymphoid cell line.

Authors:  R B Corley; J R Dawson; D B Amos
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

2.  Stimulation in primary and secondary MLC: comparison between normal lymphocytes and T and B lymphoblast cell lines before and after glutaraldehyde treatment.

Authors:  J M Brown; Y M Kong; W D Peterson; P Frost; J Kaplan; J J Lightbody
Journal:  Transplant Proc       Date:  1976-09       Impact factor: 1.066

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Failure of cultured human T-cell lymphoid lines to stimulate in mixed leukocyte culture.

Authors:  I Royston; P R Graze; R B Pitts
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

5.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

6.  B and T lymphoid cell lines.

Authors:  G E Moore; J Minowada
Journal:  N Engl J Med       Date:  1973-01-11       Impact factor: 91.245

7.  Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.

Authors:  E M Hersh; B Drewinko
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

8.  Culture of normal human leukocytes.

Authors:  G E Moore; R E Gerner; H A Franklin
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

9.  High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood.

Authors:  K Nilsson
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

10.  Immunoglobulin synthesis and secretion. VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells.

Authors:  C J Sherr; J W Uhr
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.